CO5050298A1 - Metodo y composicion para tratar impotencia - Google Patents

Metodo y composicion para tratar impotencia

Info

Publication number
CO5050298A1
CO5050298A1 CO99030405A CO99030405A CO5050298A1 CO 5050298 A1 CO5050298 A1 CO 5050298A1 CO 99030405 A CO99030405 A CO 99030405A CO 99030405 A CO99030405 A CO 99030405A CO 5050298 A1 CO5050298 A1 CO 5050298A1
Authority
CO
Colombia
Prior art keywords
composition
dinitrate
topical
treat impotence
impotence
Prior art date
Application number
CO99030405A
Other languages
English (en)
Inventor
Selim Sami
Robert Testman
Leung Fung Ho
John A Bauer
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of CO5050298A1 publication Critical patent/CO5050298A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Composiciones farmacéuticas en forma tópica o parenteral, quecontienen moninitratos dinitratos orgánicos específicos, algunos de ellos compuestos novedosos, son efectivas para tratar impotencia masculina y disfunción eréctil a través de administración tópica o intracavernosa al pene. También se exponen métodos de tratamiento que utilizan las composiciones que contienen mononitrato o dinitrato.
CO99030405A 1998-05-18 1999-05-18 Metodo y composicion para tratar impotencia CO5050298A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/081,108 US6056966A (en) 1998-05-18 1998-05-18 Method and compositions for treating impotence

Publications (1)

Publication Number Publication Date
CO5050298A1 true CO5050298A1 (es) 2001-06-27

Family

ID=22162141

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99030405A CO5050298A1 (es) 1998-05-18 1999-05-18 Metodo y composicion para tratar impotencia

Country Status (17)

Country Link
US (1) US6056966A (es)
EP (1) EP1079823A1 (es)
JP (1) JP2003511343A (es)
KR (1) KR20010071283A (es)
CN (1) CN1307472A (es)
AR (1) AR018861A1 (es)
AU (1) AU758035B2 (es)
BR (1) BR9911060A (es)
CA (1) CA2332328A1 (es)
CO (1) CO5050298A1 (es)
HU (1) HUP0101668A2 (es)
IL (1) IL139751A0 (es)
NO (1) NO20005793L (es)
PL (1) PL344335A1 (es)
SK (1) SK17452000A3 (es)
WO (1) WO1999059575A1 (es)
ZA (1) ZA200006733B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002007757A2 (en) * 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
BR0306868A (pt) * 2002-01-11 2005-04-12 David R Whitlock Composições incluindo bactérias oxidando amonìaco e métodos para usar as mesmas
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
BRPI0414813A (pt) * 2003-09-26 2006-11-14 David R Whitlock método para o uso de bactéria que oxidam a amÈnia
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070135380A1 (en) * 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070175484A1 (en) * 2006-01-30 2007-08-02 Staab Robert J Condoms for beneficial agents delivery
US8212735B2 (en) * 2009-06-05 2012-07-03 Nokia Corporation Near field communication
WO2011057386A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd. Composition and prophylactic device for enhancing sexual performance or pleasure
US9023890B2 (en) * 2009-12-02 2015-05-05 The Charlotte-Mecklenburg Hospital Authority Nitrate esters and their use for the treatment of muscle and muscle related diseases
US8471041B2 (en) * 2010-02-09 2013-06-25 Alliant Techsystems Inc. Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US9452117B2 (en) 2011-06-01 2016-09-27 The Charlotte-Mecklenburg Hospital Authority Nitrate esters and their use for the treatment of muscle and muscle related diseases
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
WO2013052803A2 (en) 2011-10-07 2013-04-11 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
JP6019126B2 (ja) 2011-10-07 2016-11-02 エピセントアーレックス・インコーポレイテッドEpicentRx, Inc. 有機ニトロチオエーテル化合物およびその医療用途
CN104352436A (zh) * 2014-10-09 2015-02-18 南京泽恒医药技术开发有限公司 一种硝酸甘油原位成形凝胶喷雾剂及其制备方法
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
KR20190040931A (ko) 2016-01-11 2019-04-19 에피센트알엑스, 인코포레이티드 2-브로모-1-(3,3-디니트로아제티딘-1-일)에타논의 정맥내 투여를 위한 조성물 및 방법
EP3526195A4 (en) 2016-10-14 2020-05-20 EpicentRx, Inc. SULFOXYALKYL ORGANONITRO AND RELATED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR USE IN MEDICINE
US11744859B2 (en) 2017-07-07 2023-09-05 Epicentrx, Inc. Compositions and methods for parenteral administration of therapeutic agents
WO2019164593A2 (en) 2018-01-08 2019-08-29 Epicentrx, Inc. Methods and compositions utilizing rrx-001 combination therapy for radioprotection
RU2757309C1 (ru) * 2020-11-02 2021-10-13 Ассим Абдель Гани Ахмед Сонбол Композиция для коррекции сексуальной дисфункции у мужчин

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps
US4913469A (en) * 1988-08-08 1990-04-03 Cameron Iron Works Usa, Inc. Wellhead slip and seal assembly
NL8802276A (nl) * 1988-09-15 1990-04-02 Cedona Pharm Bv Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.
JPH02200633A (ja) * 1989-01-27 1990-08-08 Akamatsu Shoji Kk 血管拡張剤
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
CA2158368A1 (en) * 1993-03-15 1994-09-29 Jan Bron Use of substituted alkyl nitrates for the treatment of pathologically raised intraocular pressure
HUP9801324A3 (en) * 1995-03-14 1999-03-29 Vivus Inc Menlo Park Method and kit for preventing erectile dysfunction
WO1998058633A2 (en) * 1997-06-23 1998-12-30 Queen's University At Kingston Microdose therapy of vascular conditions by no donors

Also Published As

Publication number Publication date
HUP0101668A2 (hu) 2001-10-28
AR018861A1 (es) 2001-12-12
NO20005793L (no) 2001-01-17
JP2003511343A (ja) 2003-03-25
ZA200006733B (en) 2001-09-18
PL344335A1 (en) 2001-11-05
AU758035B2 (en) 2003-03-13
SK17452000A3 (sk) 2001-08-06
NO20005793D0 (no) 2000-11-16
WO1999059575A1 (en) 1999-11-25
AU4000699A (en) 1999-12-06
KR20010071283A (ko) 2001-07-28
CN1307472A (zh) 2001-08-08
CA2332328A1 (en) 1999-11-25
IL139751A0 (en) 2002-02-10
BR9911060A (pt) 2001-02-06
US6056966A (en) 2000-05-02
EP1079823A1 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
CO5050298A1 (es) Metodo y composicion para tratar impotencia
AR002992A1 (es) Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.
BR9915822A (pt) Derivados de pirazolopirimidinona para o tratamento de impotência
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
MX9703868A (es) Inhibidores de cgmp-pde para el tratamiento de disfuncion erectil.
HK1091418A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
AR021912A1 (es) Uso de apomorfina para el tratamiento de la disfuncion erectil organica en varones
ECSP045153A (es) Metodo y composición para aumentar la potencia de un analgésico de narcotico.
ATE400258T1 (de) Transdermales buprenorphin-dosierschema zwecks schmerzstillung
DE69739970D1 (de) Methode zur behandlung sexueller fehlfunktionen
MX9400434A (es) Potenciamiento de temozolomida en celulas de tumores humanos.
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
PT1109814E (pt) 5-heterociclil pirazol¬4,3-d|pirimidina-7-onas para o tratamento da disfuncao erectil masculina
BR0110844A (pt) Composição e processo para tratar plantas
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2099293T3 (es) Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil.
ES2184300T3 (es) Derivados de aminoacidos utiles para tratar el accidente vascular encefalico.
TR28228A (tr) Deri gönlerinin islak muamelesi.
AR019327A1 (es) Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana
BR0112122A (pt) Composto de rutênio (ii) , uso de um composto, composição farmacêutica, método para tratar e/ou prevenir o câncer, e, processo para preparar um composto
SE8900835D0 (sv) Improvement in or relating to organic compounds